Blackstone Inc vs Stryker Corporation — how do they compare? Blackstone Inc trades at $146.45 (market cap $117.44B), while Stryker Corporation trades at $346.82 (market cap $133.54B). The key difference: Blackstone Inc and Stryker Corporation are close in size by market cap, and Blackstone Inc pays the higher dividend (3.55%). Which is the better fit depends on your goals.
| BX | SYK | |
|---|---|---|
Market Cap | $117.44B | $133.54B |
Sector | Financials | Technology |
52-Week High | $188.68 | $394.34 |
52-Week Low | $102.12 | $282.58 |
Dividend Yield | 3.55% | 1.01% |
Enterprise Value | — | $145.01B |
Signals from Pluang's Aura AI — not financial advice
Blackstone (BX) trades at $146.44, up 3.37% today, near its recent high. The stock shows strong earnings momentum with three consecutive quarterly beats and a robust 25.85% net income margin. Technical indicators are bullish overall, though RSI levels suggest potential overbought conditions. Recent corporate activity includes a $2.5 billion investment in Air Canada's Aeroplan loyalty program, highlighting aggressive growth initiatives.
The outlook remains positive given consistent earnings outperformance and strategic acquisitions. Key risks include market sensitivity to private equity cycles and high valuation multiples. With a consensus price target of $144.00 and 63% analyst buy ratings, Wall Street sentiment is bullish, but investors should monitor execution on large deals and broader economic trends.
Stryker (SYK) trades at $347.21, up 0.4% today, with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals, including a 9% organic sales growth in Q2 2026 and a net income margin of 14.43%. Recent news highlights recovery from a cybersecurity incident and the launch of Mako RPS, expanding its robotic surgery portfolio. Analyst consensus is overwhelmingly positive, with 74% recommending Buy and a price target of $379.44.
The outlook for SYK is favorable, driven by robust earnings growth and strategic product launches. Key risks include cybersecurity vulnerabilities and margin pressures from tariffs. With no sell ratings and strong institutional support, the stock presents a compelling opportunity for growth-oriented investors, though monitoring quarterly execution remains critical.
Trailing returns across standard periods
Latest headlines on both assets
Blackstone is one of the world's largest alternative asset managers with $940.8 billion in total asset under management, including $683.8 billion in fee-earning asset under management, at the end of June 2022.
Read more on BX →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →